Delivery Order SPE2DB22D1002-SPE2DB24FLBH4
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The $2,047.84 firm fixed-price delivery order covers the supply of Victoza 3-Pak 18 mg/3 ml Pens with a completion date of July 25, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-pak 18 mg/3 ml pens. The contract has a firm fixed price ceiling value of $3,812.88 and an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The award, valued at $9,258.42, covers the procurement of Victoza 3-Pak 18 mg/3 ml pens. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $37,452.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The contract was awarded on a Firm Fixed Price basis with an ultimate completion date of April 18, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-Pak 18 mg/3 ml pen. The contract has a ceiling value of $1,638.76 and a completion date of November 8, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $5,537.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical supplies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,343.43 firm fixed-price contract is for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through February 1, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,056.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of November 22, 2023 and is a Firm Fixed Price arrangement. This award is not designated as a set-aside contract....
- This federal contract award, valued at $5,213.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication for diabetes management. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FLBH4Delivery Order
This federal contract award, valued at $10,436.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Victoza 3-pak 18 mg/3 ml pens, a prescription medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 4/26/24 |